Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Mosliciguat [inn]
2. 2231749-54-3
3. Fl039xi4kf
4. Unii-fl039xi4kf
5. (5s)-5-((2-(4-carboxyphenyl)ethyl)(2-(2-((3-chloro-4'-(trifluoromethyl)biphenyl-4-yl)methoxy)phenyl)ethyl)amino)-5,6,7,8-tetrahydroquinoline-2-carboxylic Acid
6. 2-quinolinecarboxylic Acid, 5-((2-(4-carboxyphenyl)ethyl)(2-(2-((3-chloro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methoxy)phenyl)ethyl)amino)-5,6,7,8-tetrahydro-, (5s)-
7. Refchem:159825
8. (5s)-5-[2-(4-carboxyphenyl)ethyl-[2-[2-[[2-chloro-4-[4-(trifluoromethyl)phenyl]phenyl]methoxy]phenyl]ethyl]amino]-5,6,7,8-tetrahydroquinoline-2-carboxylic Acid
9. Orb1691102
10. Schembl25692877
11. Schembl30467081
12. Schembl30469936
13. Glxc-26878
14. Akos040757443
15. Bay-1237592
16. Da-75684
17. Hy-137446
18. Cs-0138650
| Molecular Weight | 729.2 g/mol |
|---|---|
| Molecular Formula | C41H36ClF3N2O5 |
| XLogP3 | 7.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 13 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 100 |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1150 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
39
PharmaCompass offers a list of Mosliciguat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mosliciguat manufacturer or Mosliciguat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mosliciguat manufacturer or Mosliciguat supplier.
A Mosliciguat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mosliciguat, including repackagers and relabelers. The FDA regulates Mosliciguat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mosliciguat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mosliciguat supplier is an individual or a company that provides Mosliciguat active pharmaceutical ingredient (API) or Mosliciguat finished formulations upon request. The Mosliciguat suppliers may include Mosliciguat API manufacturers, exporters, distributors and traders.
Mosliciguat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mosliciguat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mosliciguat GMP manufacturer or Mosliciguat GMP API supplier for your needs.
A Mosliciguat CoA (Certificate of Analysis) is a formal document that attests to Mosliciguat's compliance with Mosliciguat specifications and serves as a tool for batch-level quality control.
Mosliciguat CoA mostly includes findings from lab analyses of a specific batch. For each Mosliciguat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mosliciguat may be tested according to a variety of international standards, such as European Pharmacopoeia (Mosliciguat EP), Mosliciguat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mosliciguat USP).
